Swidro Wallwurz-Gel, Gel

7680569410224 CH-56941 Gel
Swidro Wallwurz-Gel, Gel
Swidro Wallwurz-Gel, Gel
Swidro Wallwurz-Gel, Gel
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/06/2022
Patient information leaflet
Français
15/06/2022
Patient information leaflet
Italien
15/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
350.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
330.0 MG Substance HBESI

Authorization holder

Alpinamed AG

9325 Roggwil TG

Authorization information

Swissmedic authorization number
56941
Drug name
Swidro Wallwurz-Gel, Gel
Galenic form
GELK
ATC Code
M02AX10
Authorization status
Z
Authorization category
Category C
Dispensing category
D
First authorization
27/04/2004
Authorization expiration date
31/12/9999
IT Number
07.10.4.
Domain
Human medicine
Field of application
Bei stumpfen Verletzungen und zur unterstützenden Behandlung bei rheumatischen Beschwerden

Package details

Description (FR)
SWIDRO gel de consoude tb 100 g
Description (DE)
SWIDRO Wallwurz Gel Tb 100 g
Market launch
27/04/2004
Narcotic (BTM)
No

Other package sizes (1)

SWIDRO gel de consoude tb 200 g
200 G
GTIN: 7680569410248
View